{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:21:27Z","timestamp":1793262087947,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chengdu Key Research and Development Support Program","award":["2024-YF09-00021-SN"],"award-info":[{"award-number":["2024-YF09-00021-SN"]}]},{"name":"Chengdu Key Research and Development Support Program","award":["2024-YF09-00021-SN"],"award-info":[{"award-number":["2024-YF09-00021-SN"]}]},{"name":"Chengdu Key Research and Development Support Program","award":["2024-YF09-00021-SN"],"award-info":[{"award-number":["2024-YF09-00021-SN"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03734-6","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T06:36:25Z","timestamp":1747982185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of blood eosinophil counts with pulmonary and extrapulmonary comorbidities in patients with chronic obstructive pulmonary disease: data from NHANES 2013\u20132018"],"prefix":"10.1186","volume":"25","author":[{"given":"Hong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"issue":"11","key":"3734_CR1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1164\/rccm.202204-0671PP","volume":"206","author":"B Celli","year":"2022","unstructured":"Celli B, Fabbri L, Criner G, Martinez FJ, Mannino D, Vogelmeier C, et al. Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision. Am J Respir Crit Care Med. 2022;206(11):1317\u201325. https:\/\/doi.org\/10.1164\/rccm.202204-0671PP","journal-title":"Am J Respir Crit Care Med"},{"key":"3734_CR2","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. In:http:\/\/www.goldcopd.org. Accessed 16 May 2024."},{"issue":"5","key":"3734_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S2213-2600(21)00511-7","volume":"10","author":"D Adeloye","year":"2022","unstructured":"Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and National prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447\u201358. https:\/\/doi.org\/10.1016\/S2213-2600(21)00511-7","journal-title":"Lancet Respir Med"},{"issue":"1","key":"3734_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12890-023-02758-0","volume":"24","author":"P Almagro","year":"2024","unstructured":"Almagro P, Soler-Catalu\u00f1a JJ, Huerta A, Gonz\u00e1lez-Segura D, Cos\u00edo BG. Impact of comorbidities in COPD clinical control criteria. The CLAVE study. BMC Pulm Med. 2024;24(1):6. https:\/\/doi.org\/10.1186\/s12890-023-02758-0","journal-title":"BMC Pulm Med"},{"issue":"1","key":"3734_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12890-023-02606-1","volume":"23","author":"H Chen","year":"2023","unstructured":"Chen H, Luo X, Du Y, He C, Lu Y, Shi Z, et al. Association between chronic obstructive pulmonary disease and cardiovascular disease in adults aged 40 years and above: data from NHANES 2013\u20132018. BMC Pulm Med. 2023;23(1):318. https:\/\/doi.org\/10.1186\/s12890-023-02606-1","journal-title":"BMC Pulm Med"},{"issue":"5","key":"3734_CR6","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1183\/09031936.00128008","volume":"33","author":"PJ Barnes","year":"2009","unstructured":"Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165\u201385. https:\/\/doi.org\/10.1183\/09031936.00128008","journal-title":"Eur Respir J"},{"issue":"4","key":"3734_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1164\/rccm.202303-0455CI","volume":"208","author":"KF Rabe","year":"2023","unstructured":"Rabe KF, Rennard S, Martinez FJ, Celli BR, Singh D, Papi A, et al. Targeting type 2 inflammation and epithelial alarmins in chronic obstructive pulmonary disease: A biologics outlook. Am J Respir Crit Care Med. 2023;208(4):395\u2013405. https:\/\/doi.org\/10.1164\/rccm.202303-0455CI","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"3734_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S2213-2600(17)30217-5","volume":"5","author":"M Bafadhel","year":"2017","unstructured":"Bafadhel M, Pavord ID, Russell R. Eosinophils in COPD: just another biomarker. Lancet Respir Med. 2017;5(9):747\u201359. https:\/\/doi.org\/10.1016\/S2213-2600(17)30217-5","journal-title":"Lancet Respir Med"},{"issue":"6","key":"3734_CR9","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1183\/09031936.00162414","volume":"44","author":"D Singh","year":"2014","unstructured":"Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44(6):1697\u2013700. https:\/\/doi.org\/10.1183\/09031936.00162414","journal-title":"Eur Respir J"},{"issue":"24","key":"3734_CR10","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1056\/NEJMoa2401304","volume":"390","author":"SP Bhatt","year":"2024","unstructured":"Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, et al. Dupilumab for COPD with blood eosinophil evidence of type 2 inflammation. N Engl J Med. 2024;390(24):2274\u201383. https:\/\/doi.org\/10.1056\/NEJMoa2401304","journal-title":"N Engl J Med"},{"issue":"3","key":"3734_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2303951","volume":"389","author":"SP Bhatt","year":"2023","unstructured":"Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Cole J, Bafadhel M, et al. Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts. N Engl J Med. 2023;389(3):205\u201314. https:\/\/doi.org\/10.1056\/NEJMoa2303951","journal-title":"N Engl J Med"},{"issue":"2","key":"3734_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.chest.2016.10.003","volume":"151","author":"S Couillard","year":"2017","unstructured":"Couillard S, Lariv\u00e9e P, Courteau J, Vanasse A. Eosinophils in COPD exacerbations are associated with increased readmissions. Chest. 2017;151(2):366\u201373. https:\/\/doi.org\/10.1016\/j.chest.2016.10.003","journal-title":"Chest"},{"issue":"21","key":"3734_CR13","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1182\/blood.2019000518","volume":"134","author":"C Marx","year":"2019","unstructured":"Marx C, Novotny J, Salbeck D, Zellner KR, Nicolai L, Pekayvaz K, et al. Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps. Blood. 2019;134(21):1859\u201372. https:\/\/doi.org\/10.1182\/blood.2019000518","journal-title":"Blood"},{"issue":"5","key":"3734_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri3831","volume":"15","author":"TA Wynn","year":"2015","unstructured":"Wynn TA. Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol. 2015;15(5):271\u201382. https:\/\/doi.org\/10.1038\/nri3831","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"3734_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20121964","volume":"210","author":"AB Molofsky","year":"2013","unstructured":"Molofsky AB, Nussbaum JC, Liang HE, Van Dyken SJ, Cheng LE, Mohapatra A, et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med. 2013;210(3):535\u201349. https:\/\/doi.org\/10.1084\/jem.20121964","journal-title":"J Exp Med"},{"issue":"17","key":"3734_CR16","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","volume":"377","author":"ID Pavord","year":"2017","unstructured":"Pavord ID, Chanez P, Criner GJ, Kerstjens H, Korn S, Lugogo N, et al. Mepolizumab for eosinophilic chronic obstructive pulmonary disease. N Engl J Med. 2017;377(17):1613\u201329. https:\/\/doi.org\/10.1056\/NEJMoa1708208","journal-title":"N Engl J Med"},{"issue":"9","key":"3734_CR17","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/s41380-018-0259-2","volume":"25","author":"KA Muscatell","year":"2020","unstructured":"Muscatell KA, Brosso SN, Humphreys KL. Socioeconomic status and inflammation: a meta-analysis. Mol Psychiatry. 2020;25(9):2189\u201399.","journal-title":"Mol Psychiatry"},{"issue":"9596","key":"3734_CR18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"issue":"4 Pt 2","key":"3734_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.lpm.2013.01.005","volume":"42","author":"F Roufosse","year":"2013","unstructured":"Roufosse F. L4. Eosinophils: how they contribute to endothelial damage and dysfunction. Presse Med. 2013;42(4 Pt 2):503\u20137. https:\/\/doi.org\/10.1016\/j.lpm.2013.01.005","journal-title":"Presse Med"},{"issue":"7","key":"3734_CR20","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.26355\/eurrev_202404_35906","volume":"28","author":"F Bozku\u015f","year":"2024","unstructured":"Bozku\u015f F, Samur A, Yaz\u0131c\u0131 O. Can blood eosinophil count be used as a predictive marker for the severity of COPD and concomitant cardiovascular disease? The relationship with the 2023 version of the global initiative for chronic obstructive lung disease staging. Eur Rev Med Pharmacol Sci. 2024;28(7):2777\u201387. https:\/\/doi.org\/10.26355\/eurrev_202404_35906","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"3734_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jaci.2005.06.031","volume":"116","author":"I Gomes","year":"2005","unstructured":"Gomes I, Mathur SK, Espenshade BM, Mori Y, Varga J, Ackerman SJ. Eosinophil-fibroblast interactions induce fibroblast IL-6 secretion and extracellular matrix gene expression: implications in fibrogenesis. J Allergy Clin Immunol. 2005;116(4):796\u2013804. https:\/\/doi.org\/10.1016\/j.jaci.2005.06.031","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"3734_CR22","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/ijms25021082","volume":"25","author":"H Zhang","year":"2024","unstructured":"Zhang H, Dhalla NS. The role of Pro-Inflammatory cytokines in the pathogenesis of cardiovascular disease. Int J Mol Sci. 2024;25(2):1082. https:\/\/doi.org\/10.3390\/ijms25021082","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3734_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/thoraxjnl-2020-215167","volume":"76","author":"B David","year":"2021","unstructured":"David B, Bafadhel M, Koenderman L, De Soyza A. Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait. Thorax. 2021;76(2):188\u201395. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-215167","journal-title":"Thorax"},{"issue":"2","key":"3734_CR24","doi-asserted-by":"publisher","first-page":"F360","DOI":"10.1152\/ajprenal.00291.2018","volume":"316","author":"S Colon","year":"2019","unstructured":"Colon S, Luan H, Liu Y, Meyer C, Gewin L, Bhave G. Peroxidasin and eosinophil peroxidase, but not myeloperoxidase, contribute to renal fibrosis in the murine unilateral ureteral obstruction model. Am J Physiol Ren Physiol. 2019;316(2):F360\u2013360371. https:\/\/doi.org\/10.1152\/ajprenal.00291.2018","journal-title":"Am J Physiol Ren Physiol"},{"issue":"11","key":"3734_CR25","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1164\/rccm.201604-0690SO","volume":"194","author":"S Roversi","year":"2016","unstructured":"Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agust\u00ed A. Chronic obstructive pulmonary disease and cardiac diseases. An urgent need for integrated care. Am J Respir Crit Care Med. 2016;194(11):1319\u201336. https:\/\/doi.org\/10.1164\/rccm.201604-0690SO","journal-title":"Am J Respir Crit Care Med"},{"key":"3734_CR26","doi-asserted-by":"publisher","first-page":"783396","DOI":"10.3389\/fphys.2021.783396","volume":"12","author":"X Xu","year":"2021","unstructured":"Xu X, Huang K, Dong F, Qumu S, Zhao Q, Niu H, et al. The heterogeneity of inflammatory response and emphysema in chronic obstructive pulmonary disease. Front Physiol. 2021;12:783396. https:\/\/doi.org\/10.3389\/fphys.2021.783396","journal-title":"Front Physiol"},{"key":"3734_CR27","doi-asserted-by":"publisher","unstructured":"Hu KC, Chuang MH, Lai CC, Liao KM. Meta-Analysis of randomized, controlled trials assessing the effectiveness and safety of biological treatments in chronic obstructive pulmonary disease patients. Clin Ther. 2025;S0149\u201329182400374\u20136 pii. https:\/\/doi.org\/10.1016\/j.clinthera.2024.12.001","DOI":"10.1016\/j.clinthera.2024.12.001"},{"key":"3734_CR28","doi-asserted-by":"publisher","first-page":"1089710","DOI":"10.3389\/fimmu.2023.1089710","volume":"14","author":"Y Wu","year":"2023","unstructured":"Wu Y, Huang M, Zhong J, Lu Y, Gan K, Yang R, et al. The clinical efficacy of type 2 monoclonal antibodies in eosinophil-associated chronic airway diseases: a meta-analysis. Front Immunol. 2023;14:1089710. https:\/\/doi.org\/10.3389\/fimmu.2023.1089710","journal-title":"Front Immunol"},{"key":"3734_CR29","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.2147\/COPD.S179425","volume":"13","author":"SH Siddiqui","year":"2018","unstructured":"Siddiqui SH, Pavord ID, Barnes NC, Guasconi A, Lettis S, Pascoe S, et al. Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis. 2018;13:3669\u201376. https:\/\/doi.org\/10.2147\/COPD.S179425","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"3734_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1136\/thoraxjnl-2015-207021","volume":"71","author":"ID Pavord","year":"2016","unstructured":"Pavord ID, Lettis S, Locantore N, Pascoe S, Jones PW, Wedzicha JA, et al. Blood eosinophils and inhaled corticosteroid\/long-acting \u03b2-2 agonist efficacy in COPD. Thorax. 2016;71(2):118\u201325. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-207021","journal-title":"Thorax"},{"issue":"10","key":"3734_CR31","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1164\/rccm.201701-0009LE","volume":"195","author":"OA Oshagbemi","year":"2017","unstructured":"Oshagbemi OA, Burden AM, Braeken D, et al. Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts. Am J Respir Crit Care Med. 2017;195(10):1402\u20134.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"3734_CR32","doi-asserted-by":"publisher","first-page":"e0163408","DOI":"10.1371\/journal.pone.0163408","volume":"11","author":"T Lucke","year":"2016","unstructured":"Lucke T, Herrera R, Wacker M, Holle R, Biertz F, Nowak D, et al. Systematic analysis of Self-Reported comorbidities in large cohort Studies - A novel Stepwise approach by evaluation of medication. PLoS ONE. 2016;11(10):e0163408. https:\/\/doi.org\/10.1371\/journal.pone.0163408","journal-title":"PLoS ONE"},{"issue":"8","key":"3734_CR33","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1097\/MLR.0000000000000753","volume":"55","author":"P St Clair","year":"2017","unstructured":"St Clair P, Gaudette \u00c9, Zhao H, Tysinger B, Seyedin R, Goldman DP. Using Self-reports or claims to assess disease prevalence: it\u2019s complicated. Med Care. 2017;55(8):782\u20138. https:\/\/doi.org\/10.1097\/MLR.0000000000000753","journal-title":"Med Care"},{"issue":"11","key":"3734_CR34","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/pds.4655","volume":"27","author":"OA Oshagbemi","year":"2018","unstructured":"Oshagbemi OA, Franssen F, Braeken D, et al. Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality. Pharmacoepidemiol Drug Saf. 2018;27(11):1191\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03734-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03734-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03734-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T06:36:28Z","timestamp":1747982188000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03734-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3734"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03734-6","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"16 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data analyzed in this study were derived from the National Health and Nutrition Examination Survey (NHANES). The study protocol received ethical approval from the Institutional Review Board of the National Center for Health Statistics (NCHS), with written informed consent obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}